The INC brings together a diverse group of stakeholders, including:
Academia: Researchers and clinicians specializing in neonatology and pediatric medicine. Industry: Pharmaceutical and biotech companies involved in developing neonatal therapies. Regulatory Authorities: Agencies like the FDA and EMA that oversee the approval of new treatments. Patient Advocacy Groups: Organizations representing the interests of neonates and their families.
